Bladder Cancer Trial, Recruiting NCT06878027 Sponsor: Regina Elena Cancer Institute Condition: Bladder Cancer
Back to Bladder Cancer

Bladder Cancer Trial, Recruiting

NCT06878027
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For patients with bladder cancer:

  • You are 18 years of age or older
  • You have a confirmed diagnosis of bladder cancer (either the type that has grown into the muscle wall or the type that has not)
  • You are generally active and able to carry out daily activities with little or no limitation (this is measured by a standard health scale called performance status 0–1 — confirm with trial site)
  • You are able to follow the steps and procedures required by the study
  • You are willing to sign a consent form agreeing to take part and allow your data to be used

For healthy volunteers:

  • You are 18 years of age or older
  • You are able to follow the steps and procedures required by the study
  • You are willing to sign a consent form agreeing to take part and allow your data to be used

Who may not be able to join:

For patients with bladder cancer:

  • Your bladder cancer has spread to other parts of the body (metastatic cancer)
  • You are not able to independently follow the study procedures

For healthy volunteers:

  • You have a past or current history of bladder cancer
  • There is any current suspicion that you may have a tumour or cancer of any kind
  • You have received or are currently receiving cancer treatments that affect the whole body (such as chemotherapy)
  • You have an inflammatory or autoimmune disease that could affect certain biological markers being measured in this study (confirm with trial site)
  • You are taking medications or receiving any other treatments that could affect the study's test results
  • You are not able to independently follow the study procedures

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +39 0652665005

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Regina Elena Cancer Institute
Registry
ClinicalTrials.gov
Start date
6 August 2024
Est. completion
6 February 2026

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Methylation state

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov